Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa StudyRoch Houot,Emmanuel Bachy,Guillaume Cartron,François-Xavier Gros,Franck Morschhauser,Lucie Oberic,Thomas Gastinne,Pierre Feugier,Remy Dulery,Catherine Thieblemont,Magalie Joris,Francisco Llamas-Gutierrez,Emmanuel Itti,Cedric Menard, Yassine Al-Tabaa,Clement Bailly,Marie-Helene Delfau,Camille Laurent,Francois LemonnierBlood(2022)引用 3|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要